过去一年中添加的文章，按日期排序

Irinotecan plus anlotinib or further in combination with penpulimab as second-line treatment of metastatic colorectal cancer (ZL-IRIAN).

C Wang, W Li, X Zhu, Q Geng, X Zhao, W Guo - 2024 - ascopubs.org
27 天前 - … effects when combined with anti-angiogenic agents with or without chemotherapy in
first- and third-line treatment for … included progress free survival (PFS), overall survival (OS), …
相关文章